Form 4: STERIS plc Senior VP Discloses Routine Tax-Related Share Dispositions Following Restricted Stock Vesting
Insider Transaction Report
John Adam Zangerle, Senior VP, General Counsel, and Secretary of STERIS plc, reported the disposition of 844 ordinary shares to cover tax obligations related to the vesting of restricted stock awards on June 2, 2025.
Summary
- John Adam Zangerle, Senior VP, General Counsel, and Secretary of STERIS plc (STE), reported transactions on June 2, 2025, related to the vesting of his restricted stock awards.
- A total of 844 ordinary shares were disposed of (withheld) by the Issuer to satisfy tax withholding requirements upon the vesting of these awards.
- The shares were valued at the NYSE closing market price of $242.08 per share on June 2, 2025.
- Specifically, 346 shares were withheld from 1,157 restricted shares awarded on May 31, 2023.
- Another 245 shares were withheld from 819 restricted shares awarded on June 2, 2021.
- And 253 shares were withheld from 846 restricted shares awarded on June 2, 2022.
- Following these transactions, Mr. Zangerle beneficially owns 32,407 ordinary shares.
- As of June 3, 2025, 6,333 of these ordinary shares remain restricted, with future vesting scheduled for June 4, 2025 (1,376 shares), October 1, 2025 (202 shares), June 1, 2026 (1,157 shares), June 2, 2026 (846 shares), June 4, 2026 (1,376 shares), and June 4, 2027 (1,376 shares).
Sentiment
Score: 5
Explanation: Neutral. This is a routine, non-discretionary transaction related to executive compensation and tax obligations, not indicative of positive or negative company performance or strategic shifts.
Positives
- The vesting of restricted shares indicates the fulfillment of long-term incentive compensation for a key executive, aligning their interests with company performance.
- The executive continues to hold a significant number of shares (32,407 ordinary shares) post-transaction, demonstrating continued alignment with shareholder interests.
Negatives
- The disposition of shares, while for tax purposes, represents a reduction in the executive's direct shareholding.
Future Outlook
This Form 4 filing reports past transactions and does not contain any forward-looking statements or guidance regarding STERIS plc's future performance or strategic outlook.
Industry Context
This document is an insider transaction report (Form 4) and does not provide information related to broader industry trends or competitive landscape for STERIS plc.
Related Party Transactions
- Disposition of shares by a senior executive to cover tax obligations arising from the vesting of restricted stock awards, which is a standard component of executive compensation.
Stakeholder Impact
- Shareholders: The transaction represents a minor, routine reduction in an executive's direct shareholding due to tax withholding, which is a common occurrence with equity compensation and does not signal a change in company fundamentals or executive confidence.
- Employees: No direct impact beyond the executive involved in the transaction.
Next Steps
- Future vesting of 6,333 restricted ordinary shares held by Mr. Zangerle on various dates through June 4, 2027, as per the established vesting schedule.
Key Dates
| Date | Description |
|---|---|
| 2021-06-02 | Award date for 819 restricted ordinary shares to Mr. Zangerle. |
| 2022-06-02 | Award date for 846 restricted ordinary shares to Mr. Zangerle. |
| 2023-05-31 | Award date for 1,157 restricted ordinary shares to Mr. Zangerle. |
| 2025-06-02 | Transaction date for the disposition of shares due to tax withholding on vested restricted stock awards; also the vesting date for 1,157, 819, and 846 restricted shares and the valuation date for vested shares. |
| 2025-06-03 | Date as of which 6,333 ordinary shares remain restricted. |
| 2025-06-04 | Vesting date for 1,376 restricted ordinary shares. |
| 2025-10-01 | Vesting date for 202 restricted ordinary shares. |
| 2026-06-01 | Vesting date for 1,157 restricted ordinary shares. |
| 2026-06-02 | Vesting date for 846 restricted ordinary shares. |
| 2026-06-04 | Vesting date for 1,376 restricted ordinary shares. |
| 2027-06-04 | Vesting date for 1,376 restricted ordinary shares. |
Recommendation
holdKeywords
STERIS plc, STE, Form 4, insider transaction, beneficial ownership, restricted stock, executive compensation, share vesting, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.